Earlier this month, fellow European drugmaker Roche Holding AG said it was looking into direct sales to bypass players like ...

AstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks Consensus Estimate. Core earnings of $2.17 per share rose 10% year over ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal ...

Stock selection in the industrials, energy and materials sectors, as well as an overweight in energy, detracted from ...

Walmart and Major League Soccer have entered into a multiyear partnership as both look to capitalize on the 2026 World Cup ...

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures ...

The automaker confirmed in a half-year update that it had already incurred levies of €300m on its US exports this year, and ...

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the United States. Revenue climbed 12 percent to ...

TACO or tariffs? An August 1 deadline looms after the European Union became the latest of the top US trading partners to ...

The United States and the European Union agreed on a framework trade deal to end months of uncertainty for industries and ...

European stocks rallied Tuesday, lifted by a slew of corporate earnings and as investors further assessed the impact of the EU-US trade agreement.US President Donald Trump's agreement with the ...

In European equities on Tuesday, the CAC 40 in Paris gained 0.6%, while the DAX 40 in Frankfurt was up 1.4%. They had ended down 0.4% and 1.0% on Monday.